An Extension Study to Provide Oraxol to Patients Who Completed KX-ORAX-007
Status:
Unknown status
Trial end date:
2019-12-01
Target enrollment:
Participant gender:
Summary
KX-ORAX-008 is an extension study of patients who completed KX-ORAX-007 without disease
progression as defined by (RECIST) v 1.1 and who wish to continue Oraxol treatment.